Results 21 to 30 of about 14,440 (242)

Elevated fecal and serum calprotectin in COVID-19 are not consistent with gastrointestinal symptoms

Scientific Reports, 2021
Intestinal epithelial cell damage caused by SARS-CoV-2 infection was thought to be associated with gastrointestinal symptoms and decreased fecal consistency.
Hajar Shokri-Afra, Ahmad Alikhani, Bahman Moradipoodeh, Farshid Noorbakhsh, Hafez Fakheri, Hemen Moradi-Sardareh   +5 more
doaj   +1 more source

EVALUATION OF FECAL ACTIVIN-A AS A NOVEL BIOMARKER FOR EARLY DIAGNOSIS OF ULCERATIVE COLITIS USING EXPERIMENTAL MURINE ANIMAL MODEL [PDF]

Assiut Veterinary Medical Journal, 2023
The present study was undertaken to evaluate fecal activin-A, in comparison with the currently used calprotectin, as a potential biomarker for early detection of ulcerative colitis (UC). Rats were divided into 4 groups (5 rats each). These included acute
KHADIGA ABOELAIL, MAHMOUD RUSHDI, AMR MOHAMED, NASHWA WALY   +3 more
doaj   +1 more source

Experimental infectious challenge in pigs leads to elevated fecal calprotectin levels following colitis, but not enteritis

Porcine Health Management, 2021
Background Fecal calprotectin is largely applied as a non-invasive intestinal inflammation biomarker in human medicine. Previous studies in pigs investigated the levels of fecal calprotectin in healthy animals only.
Jéssica A. Barbosa, Lucas A. Rodrigues, Daniel A. Columbus, Juan C. P. Aguirre, John C. S. Harding, Vinícius S. Cantarelli, Matheus de O. Costa   +6 more
doaj   +1 more source

Fecal occult blood and fecal calprotectin as point-of-care markers of intestinal morbidity in Ugandan children with Schistosoma mansoni infection. [PDF]

, 2013
BACKGROUND: Calprotectin is a calcium-binding cytoplasmic protein found in neutrophils and increasingly used as a marker of bowel inflammation. Fecal occult blood (FOB) is also a dependable indicator of bowel morbidity.
Stothard J. Russell, Kabatereine, N B, Bustinduy, Amaya L, Bustinduy, A L, Kabatereine, N, Fenwick Alan, Alan Fenwick, Betson Martha, LSHTM, Amaya L Bustinduy, Stothard, Russell; id_orcid, Narcis Kabatereine, J Russell Stothard, Ministry of Health, Uganda, Moses Adriko, Sousa-Figueiredo José C., Stothard, J Russell, Kabatereine, Narcis, Kabatereine Narcis, Betson, M, Liverpool, Bustinduy Amaya L., Betson, Martha, Adriko, M, Stothard, JR, Stothard, J R, Fenwick, A, Bustinduy, Amaya L., Sousa-Figueiredo, J C, Adriko Moses, Imperial College London, Bustinduy, AL, Sousa-Figueiredo, José C., Sousa-Figueiredo, JC, Sousa-Figueiredo, Jose C, Martha Betson, Adriko, Moses, José C Sousa-Figueiredo, Fenwick, Alan   +38 more
core   +1 more source

Faecal haemoglobin and faecal calprotectin as indicators of bowel disease in patients presenting to primary care with bowel symptoms [PDF]

, 2015
Objective In primary care, assessing which patients with bowel symptoms harbour significant disease (cancer, higher-risk adenoma or IBD) is difficult.
Wilson, Robyn, Carey, Francis A., Fraser, Callum G/, Steele, Robert J. C., Mowat, Craig; id_orcid, Digby, Jayne; id_orcid, Strachan, Judith A.   +6 more
core   +1 more source

Calprotectin and lactoferrin faecal levels in patients with Clostridium difficile infection (CDI): a prospective cohort study. [PDF]

, 2014
Measurement of both calprotectin and lactoferrin in faeces has successfully been used to discriminate between functional and inflammatory bowel conditions, but evidence is limited for Clostridium difficile infection (CDI).
Beadsworth, Mike B.J., Swale, Andrew, Mike B J Beadsworth, Munir Pirmohamed (40546), Andrew Swale, Kolamunnage-Dona, Ruwanthi, Chris M Parry, Little, Margaret, Hall, Amanda, Nick J. Beeching (623705), Parry, Chris M, Miyajima, Fabio, Paul Roberts (208537), Roberts, Paul, Fabio Miyajima, Amanda Hall, Ruwanthi Kolamunnage-Dona, Paul Roberts, Mike B. J. Beadsworth (623704), Pirmohamed, Munir, Chris M. Parry (304425), Beeching, Nick J, Munir Pirmohamed, Nick J Beeching, Beeching, Nicholas, Margaret Little (623703), Fabio Miyajima (208536), Andrew Swale (208539), Ruwanthi Kolamunnage-Dona (623706), Margaret Little, Parry, Christopher, Beadsworth, Mike BJ, Amanda Hall (210816)   +32 more
core   +1 more source

The value of fecal calprotectin in Clostridioides difficile infection: A systematic review

Frontiers in Physiology, 2022
As a marker of inflammation, calprotectin has potential application value in a variety of inflammatory diseases, such as arthritis and bacterial infections.
Bao-Jiang Wen, Bao-Jiang Wen, Bao-Jiang Wen, Li-Ger Te, Xiao-Xuan Liu, Xiao-Xuan Liu, Xiao-Xuan Liu, Jian-Hong Zhao, Jian-Hong Zhao   +8 more
doaj   +1 more source

Increased fecal calprotectin levels in Crohn's disease correlate with elevated serum Th1- and Th17-associated cytokines. [PDF]

PLoS ONE, 2018
Patient-reported symptoms and endoscopic disease activity do not correlate well in Crohn's disease (CD). This warrants the need for reliable biomarkers to early detect active intestinal inflammation.
Arno R Bourgonje, Julius Z H von Martels, Paul de Vos, Klaas Nico Faber, Gerard Dijkstra   +4 more
doaj   +1 more source

Influence of Breed Size, Age, Fecal Quality, and Enteropathogen Shedding on Fecal Calprotectin and Immunoglobulin A Concentrations in Puppies During the Weaning Period [PDF]

, 2016
BACKGROUND Fecal calprotectin and immunoglobulin A (IgA) are markers of intestinal inflammation and immunity in adult dogs. HYPOTHESIS Fecal calprotectin and IgA concentrations in puppies are not influenced by fecal moisture in puppies but by ...
C. Boucraut‐Baralon, Polack, B, B. Polack, D. Grandjean, S. Chastant‐Maillard, J.M. Steiner, Grützner, Niels, Boucraut-Baralon, Corine, Feugier, Alexandre, Grellet, A, Grellet, Aurélien, Suchodolski, J S, R.M. Heilmann, Grandjean, Dominique, Steiner, J. M., Chastant-Maillard, S., A. Grellet, Grandjean, D., Chastant-Maillard, S, N. Grützner, Boucraut-Baralon, C, Steiner, J M, Heilmann, R. M., A. Feugier, Suchodolski, J. S., Polack, Bruno, Feugier, A, Grandjean, D, Heilmann, R M, J. S. Suchodolski, Grutzner, N.   +30 more
core   +1 more source

Rational Use of Fecal Calprotectin in Irritable Bowel Syndrome and Inflammatory Bowel Disease

Acta Medica Iranica, 2021
The gastrointestinal pathologies have increased over the last years. The clinical pictures of inflammatory and irritable bowel disease might overlap, leading to expensive and invasive tests.
Roberto Catanzaro, Alfio Maugeri Maugeri, Morena Sciuto, Fang He, Baskar Balakrishnan, Francesco Marotta   +5 more
doaj   +1 more source